Skip to main content

Table 2 Distribution of the genotypes in all participants

From: Genetic variations in PRKAA1 predict the risk and progression of gastric Cancer

Genotype Controls, n (%) Patients, n (%) OR (95% CI)a p-Value
rs10074991
 AA 128(26.12) 104(21.62) Reference  
 AG 261(53.27) 255(53.01) 1.19(0.87,1.62) 0.283
 GG 101(20.61) 122(25.36) 1.44(0.99,2.09) 0.056
 AG/GG 362(73.88) 377(78.38) 1.26(0.94,1.70) 0.127
 Additive model    1.21(1.01, 1.46) 0.042
rs13361707
 TT 129(26.33) 103(21.41) Reference  
 TC 260(53.06) 256(53.22) 1.22(0.89,1.66) 0.219
 CC 101(20.61) 122(25.36) 1.47(1.01,2.14) 0.043
 TC/CC 361(73.67) 365(75.88) 1.29(0.96,1.74) 0.093
 Addictive model    1.22(1.02,1.47) 0.033
rs154268
 TT 297(60.61) 271(56.34) Reference  
 TC 176(35.92) 179(37.21) 1.13(0.86,1.47) 0.388
 CC 17(3.47) 31(6.44) 1.96(1.06,3.63) 0.033
 TC/CC 193(39.39) 210(43.66) 1.20(0.93,1.56) 0.158
 Additive model    1.24(1.00,1.53) 0.053
rs6882903
 CC 342(69.80) 312(64.86) Reference  
 CA 134(27.35) 149(30.98) 0.86(0.41,1.80) 0.687
 AA 14(2.86) 20(4.16) 1.56(0.77,3.15) 0.217
 CA/AA 148(30.20) 169(35.14) 1.26(0.96,1.65) 0.097
 Additive model    1.23(0.98,1.55) 0.078
rs3805490
 TT 279(56.94) 280(58.21) Reference  
 TA 181(36.94) 170(35.34) 0.93(0.71,1.21) 0.567
 AA 30(6.12) 31(6.44) 1.02(0.60,1.73) 0.953
 TA/AA 211(43.06) 201(41.79) 0.94(0.73,1.21) 0.627
 Additive model    0.97(0.79,1.19) 0.756
rs461404
 AA 298(60.82) 270(56.13) Reference  
 GA 175(35.71) 179(37.21) 1.14(0.87,1.49) 0.341
 GG 17(3.47) 32(6.65) 2.05(1.11,3.78) 0.022
 GA/GG 192(39.18) 211(43.87) 1.22(0.95,1.58) 0.125
 Additive model    1.26(1.01,1.56) 0.037
  1. aAdjusted for age, gender, smoking, drinking, and Helicobacter pylori infection